The covid vaccines and boosters are still in the news despite their inefficiency in preventing transmission. Check out the latest reports coming from Moderna below.
Moderna reveals news about covid boosters
The data indicate that Moderna’s new booster generates significantly higher levels of neutralizing antibodies against the subvariant, BA.5, and another omicron subvariant, BA.4, than the previous booster.
A new study by Moderna revealed the fact that its updated coronavirus booster strengthens a key component of the immune system’s defense against the omicron subvariant that accounted for most infections in the United States in recent months.
The company revealed the findings in a news release Monday. “The underlying data has not yet been published or peer-reviewed, but it has been reviewed by federal regulators,” according to the latest reports.
“We are pleased to see that both of our bivalent booster vaccine candidates offer superior protection against Omicron BA.4/BA.5 variants compared to our original booster, which is encouraging given COVID-19 remains a leading cause of hospitalization and death globally. In addition, the superior response against Omicron persisted for at least three months after the mRNA-1273.214 booster,” said Stéphane Bancel, Moderna’s Chief Executive Officer.
She continued and said the following:
“Our bivalent boosters also show, in research assays, neutralizing activity against BQ.1.1, an increasingly dominant emerging variant, confirming that updated vaccines have the potential to offer protection as the virus continues to evolve rapidly to escape our immunity.”
Check out the original press release here.
Covid news – AstraZeneca drops news about the covid vaccine
It’s been just reported that AstraZeneca is no longer pursuing U.S. approval of its COVID-19 vaccine, Chief Executive Pascal Soriot said in a media call on Thursday.
Demand for vaccines in the country is declining and the market is well served by the mRNA shots, he said, according to the same reports.
The company has been making a lot of headlines in relation to the vaccine.
